Juan G. Posada

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10

Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: <scp>KEYNOTE</scp>‐013

Vincent Ribrag, David Avigan, Damian J. Green et al. · British Journal of Haematology · 2019 · 81 citations · Full text

Pembrolizumab Monotherapy, Immunology, Immunoediting +19

Amsacrine-associated cardiotoxicity: an analysis of 82 cases.

R B Weiss, A.J. Grillo-López, Silvia Marsoni et al. · Journal of Clinical Oncology · 1986 · 63 citations

Ecg Abnormalities, Antileukemia Drug, Heart Failure +12

Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience

Juan Naranjo-Escobar, Eliana Manzi, Juan G. Posada et al. · Lupus · 2017 · 31 citations

Glomerulonephritis, Transplantation Surgery, Urology +15

Kidney Transplantation and Gastric Bypass: A Better Control of Comorbidities

Rafael Arias, Liliana Mesa, Juan G. Posada et al. · Obesity Surgery · 2010 · 22 citations

Transplantation Surgery, Transplantation, Intestinal Transplantation +9